Boyd Consultants

Executive Summary

Boyd Consultants is a London-based global drug development consultancy providing expert regulatory affairs and strategic advisory services to the biotech and pharmaceutical industries. With a strong track record in advanced therapies such as cell and gene therapies, Boyd supports clients from concept to approval, offering integrated clinical, medical, and regulatory solutions. The firm collaborates with pharmaceutical companies, biotech firms, spin-outs, and academic groups, helping to accelerate the development of new medicines. Given the increasing complexity of drug development and the rise of advanced therapeutic modalities, Boyd is well-positioned to benefit from growing demand for specialized regulatory and development expertise. The consultancy's deep knowledge of global regulatory pathways and its ability to navigate evolving guidelines make it a valuable partner for companies seeking to bring innovative therapies to market efficiently.

Upcoming Catalysts (preview)

• Q3 2026Announcement of major partnership with leading cell/gene therapy developer60% success
• Q4 2026Expansion into additional geographic markets (e.g., Asia-Pacific)50% success
• Q2 2026Key leadership hire in a high-demand therapeutic area70% success